Greg Shaw
-
- Prostate Cancer Treatment and Research 31
- Prostate Cancer Diagnosis and Treatment 30
- Kidney Stones and Urolithiasis Treatments 4
- Urology top 5%
- Urinary Bladder and Prostate Research 6
- Urological Disorders and Treatments 5
- Cancer Research top 10%
- Rheumatology top 5%
- Urologic and reproductive health conditions 7
-
- Bladder and Urothelial Cancer Treatments 5
-
- Epigenetics and DNA Methylation 4
Greg Shaw
69 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 130
- Pulmonary and Respiratory Medicine 742
- Urology 139
- Cancer Research 200
- Rheumatology 170
- Oncology 186
Countries citing papers authored by Greg Shaw
This map shows the geographic impact of Greg Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Shaw more than expected).
Fields of papers citing papers by Greg Shaw
This network shows the impact of papers produced by Greg Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Shaw. The network helps show where Greg Shaw may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Greg Shaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 11 | |
| 5 | 2022 | 17 | |
| 6 | 2019 | 22 | |
| 7 | 2019 | 13 | |
| 8 | 2019 | 2 | |
| 9 | Test methodology for evaluating the reclined seating environment with human surrogates | 2019 | 6 |
| 10 | 2018 | 2 | |
| 11 | 2017 | 54 | |
| 12 | 2017 | 25 | |
| 13 | 2017 | 49 | |
| 14 | 2016 | 32 | |
| 15 | 2014 | 24 | |
| 16 | 2008 | 39 | |
| 17 | 2007 | 1 | |
| 18 | 2007 | 1 | |
| 19 | 2007 | 6 | |
| 20 | 2004 | 35 |
About Greg Shaw
Greg Shaw is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 76 papers that have together received 1.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (31 papers), Prostate Cancer Diagnosis and Treatment (30 papers), Urologic and reproductive health conditions (7 papers), Urinary Bladder and Prostate Research (6 papers), Bladder and Urothelial Cancer Treatments (5 papers), Urological Disorders and Treatments (5 papers), Kidney Stones and Urolithiasis Treatments (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (742 citations), Urology (139 citations) and Cancer Research (200 citations). Greg Shaw has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include David M. Prowse, R.T.D. Oliver, Ashwin Sridhar, Alex Freeman, David E. Neal, John D. Kelly, Jack Cuzick, Senthil Nathan, Xueying Mao and Daniel M. Berney. Their work appears in journals such as British Journal of Urology, Urology, British Journal of Cancer, The Journal of Urology and Histopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.